Radiomics-based prediction of HCC response to atezolizumab/bevacizumab.

被引：0
|
作者：
Rodriguez, Isaac
Vellala, Abhinay
Itzel, Timo
Vacha, Michael
Chang, De-Hua
Dill, Michael
Seidensticker, Max
Mayerle, Julia
Munker, Stefan
Schoenberg, Stefan O.
Mueller, Lukas
Galle, Peter Robert
Weinmann, Arndt
Tamandl, Dietmar
Pinter, Matthias
Scheiner, Bernhard
Teufel, Andreas
Froelich, Matthias
Ebert, Matthias Philip
Venerito, Marino
机构：
[1] Heidelberg Univ, Med Fac Mannheim, Div Hepatol, Div Hepatol,Div Clin Bioinformat, Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Dept Radiol Nucl Med, Mannheim, Germany
[3] Heidelberg Univ, Med Fac Mannheim, Ctr Prevent Med & Digital Hlth Baden Wurttemberg C, Clin Cooperat Unit Hlth Metab, Mannheim, Germany
[4] Cantonal Hosp Lucerne, Dept Radiol, Luzern, Switzerland
[5] Heidelberg Univ Hosp, Dept Gastroenterol Hepatol Infect Dis & Intoxicat, Heidelberg, Germany
[6] Univ Hosp Munich Grosshadern, Munich, Germany
[7] Univ Hosp Munich Grosshadern, Munich, Germany
[8] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 2, Munich, Germany
[9] Univ Med Mannheim, Mannheim, Germany
[10] Univ Med Ctr Mainz, Dept Diagnost & Intervent Radiol, Mainz, Germany
[11] Univ Med Ctr Mainz, I Dept Med, Mainz, Germany
[12] Med Univ Wien, Vienna, Austria
[13] Med Univ Vienna, Hepatol AKH, Vienna, Austria
[14] Med Univ Vienna, Dept Internal Medicine3, Div Gastroenterol & Hepatol, Vienna, Austria
[15] Heidelberg Univ, Mannheim, Germany
[16] Heidelberg Univ, Med Fac Mannheim, Dept Pathol, Mannheim, Germany
[17] Ultratendency Magdeburg, Magdeburg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.636
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [21] Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases
    Peng Du
    Xiao Liu
    Rui Xiang
    Kun Lv
    Hongyi Chen
    Weifan Liu
    Aihong Cao
    Lang Chen
    Xuefeng Wang
    Tonggang Yu
    Jian Ding
    Wuchao Li
    Jie Li
    Yuxin Li
    Zekuan Yu
    Li Zhu
    Jie Liu
    Daoying Geng
    European Radiology, 2023, 33 : 8925 - 8935
  • [22] Radiomics-based model for outcome prediction in primary sclerosing cholangitis
    Cristoferi, Laura
    Porta, Marco
    Bernasconi, Davide
    Filippo, Leonardi
    Mulinacci, Giacomo
    Palermo, Andrea
    Gerussi, Alessio
    Scaravaglio, Miki
    Gallo, Camilla
    Stucchi, Eliana
    Maino, Cesare
    Ippolito, Davide
    D'Amato, Daphne
    Ferreira, Carlos
    Mavar-Haramija, Marija
    Banerjee, Rajarshi
    Antolini, Laura
    Valsecchi, Maria Grazie
    Fagiuoli, Stefano
    Invernizzi, Pietro
    Carbone, Marco
    JOURNAL OF HEPATOLOGY, 2022, 77 : S96 - S96
  • [23] Radiomics-based biomarker for PD-1 status and prognosis analysis in patients with HCC
    Hapaer, Gulizaina
    Che, Feng
    Xu, Qing
    Li, Qian
    Liang, Ailin
    Wang, Zhou
    Ziluo, Jituome
    Zhang, Xin
    Wei, Yi
    Yuan, Yuan
    Song, Bin
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [24] Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer
    Bologna, Marco
    Calareso, Giuseppina
    Resteghini, Carlo
    Sdao, Silvana
    Montin, Eros
    Corino, Valentina
    Mainardi, Luca
    Licitra, Lisa
    Bossi, Paolo
    NMR IN BIOMEDICINE, 2022, 35 (04)
  • [25] Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
    Zhou, Xuezhi
    Yi, Yongju
    Liu, Zhenyu
    Cao, Wuteng
    Lai, Bingjia
    Sun, Kai
    Li, Longfei
    Zhou, Zhiyang
    Feng, Yanqiu
    Tian, Jie
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (06) : 1676 - 1684
  • [26] Plasma Protein- and Radiomics-based Prediction of Tumor Response to Modified FOLFIRINOX in Pancreatic Ductal Adenocarcinoma
    Zhang, Q.
    Lou, Y.
    Tang, T.
    Bai, X.
    Liang, T.
    PANCREAS, 2019, 48 (10) : 1561 - 1561
  • [27] Conversion response and prognostic factors in HCC patients with macrovascular invasion treated with atezolizumab plus bevacizumab
    Wang, K.
    Sun, H.
    Bai, X.
    Huang, Z-Y.
    Song, T.
    Chen, M.
    Kuang, M.
    Xiang, B.
    Zeng, Y.
    Liu, L-X.
    Li, D.
    Chen, Y.
    Cai, J.
    Xing, B.
    Peng, T.
    Zhang, X.
    Zhu, X.
    Zhou, J.
    Fan, J.
    Shen, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S1541 - S1541
  • [28] Deep learning radiomics-based preoperative prediction of recurrence in chronic rhinosinusitis
    He, Shaojuan
    Chen, Wei
    Li, Anning
    Xie, Xinyu
    Liu, Fangying
    Ma, Xinyi
    Feng, Xin
    Wang, Xuehai
    Li, Xuezhong
    ISCIENCE, 2023, 26 (04)
  • [29] Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology images
    Michlikova, S.
    Meneghetti, A. Rabasco
    Loeck, S.
    Yakimovich, A.
    Rassamegevanon, T.
    von Neubeck, C.
    Dietrich, A.
    Krause, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S593 - S593
  • [30] Computed Tomography Radiomics-Based Prediction of Microvascular Invasion in Hepatocellular Carcinoma
    Yao, Wenjun
    Yang, Shuo
    Ge, Yaqiong
    Fan, Wenlong
    Xiang, Li
    Wan, Yang
    Gu, Kangchen
    Zhao, Yan
    Zha, Rujing
    Bu, Junjie
    FRONTIERS IN MEDICINE, 2022, 9
12345